Advances in medical decision support systems for diagnosis of acute graft-versus-host disease: Molecular and computational intelligence joint approaches

Frontiers of Biology in China

Volumn 6, Issue 4, 2011, Pages 263-273

  Fiasché, Maurizio ^a,b   Cuzzola, Maria ^b   Irrera, Giuseppe ^b   Iacopino, Pasquale ^c   Morabito, Francesco Carlo ^a  

^a UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

^b Transplant Regional Center of Stem Cells and Cellular Therapy   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

Author keywords

computational intelligence; gene selection; GVHD; machine learning; personalized modelling; wrapper

Indexed keywords

EID: 79961057483     PISSN: 16733509     EISSN: 16733622     Source Type: Journal    
DOI: 10.1007/s11515-011-1124-8     Document Type: Review

References (47)

1. Ayuk F, Diyachenko G, Zabelina T, Panse J, Wolschke C, Eiermann T, Binder T, Fehse B, Erttmann R, Kabisch H, Bacher U, Kröger N, Zander A R (2008). Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors. Exp Hematol, 36(8): 1047-1054.
2. Bacigalupo A, Lamparelli T, Milone G, Sormani M P, Ciceri F, Peccatori J, Locasciulli A, Majolino I, Di Bartolomeo P, Mazza F, Sacchi N, Pollicheni S, Pinto V, van Lint M T, the Gruppo Italiano Trapianto Midollo Osseo (GITMO) (2010). Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day + 7 after alternative donor transplants. Bone Marrow Transplant, 45(2): 385-391.
3. Beilhack A, Schulz S, Baker J, Beilhack G F, Wieland C B, Herman E I, Baker E M, Cao Y A, Contag C H, Negrin R S (2005). In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. Blood, 106(3): 1113-1122.
4. Brodoefel H, Bethge W, Vogel M, Fenchel M, Faul C, Wehrmann M, Claussen C, Horger M (2010). Early and late-onset acute GVHD following hematopoietic cell transplantation: CT features of gastrointestinal involvement with clinical and pathological correlation. Eur J Radiol, 73(3): 594-600.
5. Buzzeo M P, Yang J, Casella G, Reddy V (2008). A preliminary gene expression profile of acute graft-versus-host disease. Cell Transplant, 17(5): 489-494.
6. Chaussabel D, Pascual V, Banchereau J (2010). Assessing the human immune system through blood transcriptomics. BMC Biol, 8(1): 84-98.
7. Ferrara J L (2008). Advances in the clinical management of GVHD. Best Pract Res Clin Haematol, 21(4): 677-682.
8. Ferrara J L, Levine J E, Reddy P, Holler E (2009). Graft-versus-host disease. Lancet, 373(9674): 1550-1561.
9. Ferrara J L, Reddy P (2006). Pathophysiology of graft-versus-host disease. Semin Hematol, 43(1): 3-10.
10. Fiasché M (2010). Implementations of Evolving Integrated Multimodel Systems, Algorithms and Applications in Biomedical Field. DissertationTip. DIMET, University "Mediterranea" of Reggio Calabria.
11. Fiasché M, Cuzzola M, Fedele R, Iacopino P, Morabito F C (2010a). Machine Learning and Personalized Modelling based Gene Selection for acute GvHD Gene Expression Data Analysis. In: Artificial Neural Networks - proceedings of ICANN 2010 Part I, LNCS6352.
12. Fiasché M, Cuzzola M, Iacopino P, Kasabov N, Morabito F C (2010b). Personalized Modelling based Gene Selection for acute GvHD Gene Expression Data Analysis: a Computational Framework Proposed. Australian Journal of Intelligent Information Processing Systems, 12(4): Machine Learning Applications (Part II).
13. Fiasché M, Verma A, Cuzzola M, Iacopino P, Kasabov N, Morabito F C (2009). Discovering Diagnostic Gene Targets and Early Diagnosis of Acute GVHD Using Methods of Computational Intelligence over Gene Expression Data. In: Artificial Neural Networks - ICANN 2009. Part II, LNCS 5769/2009, Berlin: Springer Heidelberg, pp. 10-19.
14. Firoz B F, Lee S J, Nghiem P, Qureshi A A (2006). Role of skin biopsy to confirm suspected acute graft-vs-host disease: results of decision analysis. Arch Dermatol, 142(2): 175-182.
15. Foley J E, Mariotti J, Ryan K, Eckhaus M, Fowler D H (2008). Th2 cell therapy of established acute graft-versus-host disease requires IL-4 and IL-10 and is abrogated by IL-2 or host-type antigen-presenting cells. Biol Blood Marrow Transplant, 14(9): 959-972.
16. Fujimura J, Takeda K, Kaduka Y, Saito M, Akiba H, Yagita H, Yamashiro Y, Shimizu T, Okumura K (2010). Contribution of B7RP-1/ICOS co-stimulation to lethal acute GVHD. Pediatr Transplant, 14(4): 540-548.
17. Guyon I, Elisseeff A (2003). An introduction to variable and feature selection. J Mach Learn Res, 3(7-8): 1157-1182.
18. Harik G R, Lobo F G, Goldberg D E (1999). The compact genetic algorithm. IEEE Trans Evol Comput, 3(4): 287-297.
19. Ho V T, Cutler C (2008). Current and novel therapies in acute GVHD. Best Pract Res Clin Haematol, 21(2): 223-237.
20. Hu Y, Song Q, Kasabov N (2009). Personalized modelling based gene selection for microarray data analysis. In: Köppen M, Kasabov N, Coghill G (eds.). ICONIP 2008, Part I. LNCS. Springer, Heidelberg, vol. 5506, pp. 1221-1228.
21. Jacobsohn D A, Vogelsang G B (2007). Acute graft versus host disease. Orphanet J Rare Dis, 2(1): 35-44.
22. Lord J D, Hackman R C, Gooley T A, Wood B L, Moklebust A C, Hockenbery D M, Steinbach G, Ziegler S F, McDonald G B (2011). Blood and gastric FOXP3+ T cells are not decreased in human gastric graft versus host disease. Biol Blood Marrow Transplant, 17(4): 486-496.
23. Kasabov N (2007a). Evolving Connectionist Systems: The Knowledge Engineering Approach, 2nd ed. Springer, London.
24. Kasabov N (2007b). Global, local and personalized modelling and profile discovery in bioinformatics: An integrated approach. Pattern Recognit Lett, 28(6): 673-685.
25. Kasabov N (2010). To spike or not to spike: A probabilistic spiking neural model. Neural Networks, 23(1): 16-19.
26. + T cells mediating graft-versus-host disease. Biol Blood Marrow Transplant, 16(6): 751-771.
27. Langley P (1994). Selection of relevant features in machine learning, In: Proceedings of AAAI Fall Symposium on Relevance, 140-144.
28. + regulatory T cells has diagnostic and prognostic value as a biomarker for acute graftversus-host-disease. Biol Blood Marrow Transplant, 16(7): 907-914.
29. Miura Y, Thoburn C J, Bright E C, Phelps M L, Shin T, Matsui E C, Matsui W H, Arai S, Fuchs E J, Vogelsang G B, Jones R J, Hess A D (2004). Association of Foxp3 regulatory gene expression with graftversus-host disease. Blood, 104(7): 2187-2193.
30. Mohty M, Gaugler B, Faucher C, Sainty D, Lafage-Pochitaloff M, Vey N, Bouabdallah R, Arnoulet C, Gastaut JA, Viret F, Wolfers J, Maraninchi D, Blaise D, Olive D (2002). Recovery of lymphocyte and dendritic cell subsets following reduced intensity allogeneic bone marrow transplantation. Hematology, 7(3): 157-64.
31. Paczesny S, Braun T M, Levine J E, Hogan J, Crawford J, Coffing B, Olsen S, Choi S W, Wang H, Faca V, Pitteri S, Zhang Q, Chin A, Kitko C, Mineishi S, Yanik G, Peres E, Hanauer D, Wang Y, Reddy P, Hanash S, Ferrara J L M (2010a). Elafin is a biomarker of graftversus-host disease of the skin. Sci Transl Med, 2(13): ra2.
32. Paczesny S, Hanauer D, Sun Y, Reddy P (2010b). New perspectives on the biology of acute GVHD. Bone Marrow Transplant, 45(1): 1-11.
33. Paczesny S, Krijanovski O I, Braun T M, Choi S W, Clouthier S G, Kuick R, Misek D E, Cooke K R, Kitko C L, Weyand A, Bickley D, Jones D, Whitfield J, Reddy P, Levine J E, Hanash S M, Ferrara J L M (2009a). A biomarker panel for acute graft-versus-host disease. Blood, 113(2): 273-278.
34. Paczesny S, Levine J E, Braun T M, Ferrara J L M (2009b). Plasma biomarkers in graft-versus-host disease: a new era? Biol Blood Marrow Transplant, 15(Suppl): 33-38.
35. Payne D K, Sullivan M D, Massie M J (1996). Women's psychological reactions to breast cancer. Semin Oncol, 23(Suppl 2): 89-97.
36. Piper K P, Horlock C, Curnow S J, Arrazi J, Nicholls S, Mahendra P, Craddock C, Moss P A H (2007). CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation. Blood, 110(12): 3827-3832.
37. Platt J (1998). Fast training of support vector machines using sequential minimal optimization. Advances in Kernel Methods-Support Vector Learning. MIT Press.
38. Schub N, Günther A, Schrauder A, Claviez A, Ehlert C, Gramatzki M, Repp R (2011). Therapy of steroid-refractory acute GVHD with CD52 antibody alemtuzumab is effective. Bone Marrow Tranplant, 46: 143-147.
39. Socié G (2009). Graft-versus-host disease: proteomics comes of age. Blood, 113(2): 271-272.
40. Socié G, Blazar B R (2009). Acute graft-versus-host disease: from the bench to the bedside. Blood, 114(20): 4327-4336.
41. Song Q, Kasabov N (2006). TWNFI - Transductive weighted neurofuzzy inference system and applications for personalized modelling. Neural Netw, 19(10): 159-596.
42. van Bekkum D W, Vries De M J (1967). Radiation Chimaeras, London: Logos Press.
43. Varadi G, Or R, Slavin S, Nagler A (1996). In vivo CAMPATH-1 monoclonal antibodies: a novel mode of therapy for acute graftversus-host disease. Am J Hematol, 52(3): 236-237.
44. Verma A, Fiasché M, Cuzzola M, Iacopino P, Morabito F C, Kasabov N (2009). Ontology Based Personalized Modelling for Type 2 Diabetes Risk Analysis: An Integrated Approach. In: Leung C S, Lee M, Chan J H (Eds.): ICONIP 2009, Part II, LNCS 5864, Springer, Heidelberg, pp. 360-366.
45. Weissinger E M, Schiffer E, Hertenstein B, Ferrara J L, Holler E, Stadler M, Kolb H J, Zander A, Zürbig P, Kellmann M, Ganser A (2007). Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Blood, 109(12): 5511-5519.
46. Wolf D, Wolf AM, Fong D, Rumpold H, Strasak A, Clausen J, Nachbaur D (2007). Regulatory T-cells in the graft and the risk of acute graftversus-host disease after allogeneic stem cell transplantation. Transplantation, 83(8): 1107-1113.
47. Yu X Z, Liang Y, Nurieva R I, Guo F, Anasetti C, Dong C (2006). Opposing effects of ICOS on graft-versus-host disease mediated by CD4 and CD8 T cells. J Immunol, 176(12): 7394-7401.